Attending the program were Ms. Le Nguyen Lan Anh – Member of the Standing Committee of the Vinh Long Provincial Labor Federation; Ms. Nguyen Thi Thu Huong – CEO of Cuu Long Pharmaceutical Joint Stock Company; Mr. Nguyen Toan Thang – CEO of Benovas Medical Devices; members of the Company’s Trade Union Executive Committee; and employee representatives from across the system.

The conference was organized to promote employees’ rights to participation and ownership, strengthen democratic dialogue in the workplace, and create opportunities for the Company’s leadership and employees to directly exchange, listen, and share issues related to policies, benefits, and development orientations in the coming period.

In her opening speech, Ms. Nguyen Thi Thu Huong emphasized the important role of employees in the Company’s sustainable development journey. In the context of an increasingly competitive pharmaceutical market and rising quality requirements, human resources continue to be identified as a core factor contributing to the enhancement of production capacity, governance, and long-term development.

At the conference, representatives of the Board of Management presented reports on the Company’s 2025 business performance and the production and business plan for 2026. Accordingly, Cuu Long Pharmaceutical will continue maintaining stable production operations, gradually improving operational efficiency, enhancing quality, and optimizing competitiveness in the market.

In addition to business-related matters, the conference also spent considerable time reviewing the implementation of employee policies and benefits, the Collective Labor Agreement, grassroots democracy regulations, and employee welfare, reward, and support activities over the past period.

One of the most anticipated parts of the program was the direct dialogue session between employees and representatives of the Employer. Discussions focused on practical issues such as salary and bonus policies, employee welfare, working hours, working conditions, as well as solutions to improve the working environment and employees’ spiritual well-being.

With an open, straightforward, and constructive spirit, the Company’s leadership directly addressed many employee concerns and recommendations, while acknowledging appropriate proposals for further consideration and improvement in the future. The discussions at the conference not only demonstrated the Company’s care for employees but also contributed to strengthening internal unity, mutual understanding, and a stable, sustainable working environment.

Within the framework of the program, the signing ceremony of the Collective Labor Agreement between the Employer representative and the employee representatives also took place. The agreement was signed by Ms. Nguyen Thi Thu Huong and Mr. Nguyen Van Hoang – Chairman of the Company’s Trade Union.

Held annually, Vietnam Medi-Pharm is one of the largest and most prestigious exhibitions in Vietnam’s healthcare and pharmaceutical sector, bringing together hundreds of domestic and international enterprises operating in pharmaceuticals, medical equipment, healthcare technologies, and hospital solutions. This year’s exhibition once again attracted significant attention from experts, doctors, distributors, and businesses across the industry.

Through the event, BMD had the opportunity to meet and exchange with partners, experts, and enterprises in the healthcare field, thereby expanding its network and gaining deeper insights into the practical demands of the market. The exhibition also allowed the company to access emerging technologies and healthcare solutions currently attracting industry attention.

A representative of BMD shared that Vietnam Medi-Pharm is not only an important networking event for the healthcare and pharmaceutical sector but also an opportunity for businesses to capture market trends, explore cooperation opportunities, and enhance competitiveness amid rapid changes in the healthcare industry.

“Participating in Vietnam Medi-Pharm 2026 gives BMD more opportunities to connect with the professional community, update the latest technology trends, and listen to real market demands. This also serves as a foundation for the Company to further refine its product development orientation and improve service quality in the coming period,” said Mr. Nguyen Toan Thang – General Director of BMD.

As the healthcare sector increasingly focuses on treatment quality, equipment standardization, and the application of technology in healthcare services, participation in industry events is considered an important opportunity for businesses to expand partnerships, strengthen professional capabilities, and improve adaptability to market needs.

With a sustainable development orientation, BMD is gradually expanding connections with domestic and international partners while continuously updating technologies and improving operational quality to meet the growing demands of the healthcare industry.

Participation in Vietnam Medi-Pharm 2026 once again demonstrates BMD’s active presence at major industry events, thereby contributing to enhancing the company’s image, promoting cooperative connections, and reaffirming its commitment to accompanying the development of Vietnam’s healthcare sector.

The ceremony was attended by Mr. Nguyen Van Sang – Chairman of the Board of Directors, members of the Group’s Board of Management, and leaders of affiliated subsidiaries. The presence of leadership representatives at all levels reflected the Company’s strong emphasis on human resources as a key factor in its sustainable development strategy.

Speaking at the event, Mr. Nguyen Van Sang emphasized the critical role of the leadership team in driving growth and enhancing organizational capabilities. According to him, appointing the right personnel not only meets operational requirements but also creates momentum for development in an increasingly competitive market environment.

During the ceremony, Duoc Cuu Long officially announced the appointment of Mr. Pham Chung Dinh as Deputy Chief Executive Officer in charge of the Pharmaceutical Market Division. Mr. Dinh possesses many years of experience in the pharmaceutical industry and has previously held senior executive positions in business management. He is highly regarded for his strategic mindset, organizational capabilities, and in-depth understanding of the market.

Ông Phạm Chung Đỉnh – Tân Phó Tổng Giám đốc Kinh doanh phụ trách Khối thị trường Dược phẩm DCL.

The appointment of Mr. Pham Chung Dinh is expected to contribute to improving business performance, expanding market presence, and optimizing management and operational efficiency. In his remarks upon accepting the new role, Mr. Dinh stated that he would work closely with the team to implement solutions aimed at developing the pharmaceutical business in an efficient and sustainable manner.

Continuing the program, the Company also announced the appointment of Mr. Ho Ngoc Dung as Director of Benovas Capsule One Member Limited Liability Company. This leadership consolidation takes place as the Capsule factory transitions to independent operations, with the goal of enhancing operational autonomy and specialization.

Before assuming his new position, Mr. Ho Ngoc Dung made significant contributions as Capsule Sales Director, achieving revenue of VND 320 billion in 2024, representing 12% growth while also expanding the market and maintaining a strong domestic market share. In addition to business achievements, he also played an important role in building the customer network and developing a professional and effective sales team.

Ông Hồ Ngọc Dũng được bổ nhiệm giữ chức vụ Giám đốc Công ty TNHH MTV Benovas Capsule

Speaking after receiving the appointment decision, Mr. Ho Ngoc Dung shared the development orientation for the coming period and expressed his determination to work together with the Benovas Capsule team to maintain the Company’s leading position, improve product quality, and further expand the market.

The ceremony concluded in a formal and optimistic atmosphere. The appointment of these two important leadership positions not only strengthens the organizational structure but also clearly demonstrates the Company’s commitment to placing people at the center of its development strategy.

With the capabilities, experience, and leadership qualities of the newly appointed executives, Duoc Cuu Long is entering a promising stage of stronger growth, enhanced competitiveness, and continued efforts to reinforce its position in the domestic pharmaceutical market while gradually expanding its regional presence.

The 2026 Annual Scientific and Technical Conference, organized by the Ho Chi Minh City Society of Medical Biochemistry, attracted a large number of experts, doctors, scientists, and businesses operating in the fields of testing and diagnostics. The event served as an important forum for updating professional knowledge, sharing practical experience, and promoting the application of technological advances in biochemistry and immunology.

Accompanying the event, BMD introduced a booth showcasing high-quality medical device products. The company’s booth attracted considerable attention from visitors, especially doctors and laboratory technicians from hospitals and medical centers. BMD presented a diverse portfolio of products, including syringes, insulin syringes, infusion sets, and more, meeting treatment and patient care needs across various healthcare facilities. The products are designed according to strict quality standards, focusing on safety, precision, and convenience during use.

Beyond product exhibition activities, Benovas actively engaged in professional exchanges and listened to feedback from leading experts in order to further improve its products and service quality. The event also provided the company with an opportunity to stay updated on emerging trends and the real needs of the healthcare system.

Speaking at the conference, Mr. Nguyen Toan Thang – General Director of BMD, stated: “Participating in this year’s conference not only helps BMD introduce our key products to the professional community, but also provides an important opportunity for us to listen to the practical needs of healthcare facilities. This enables the company to continue improving and developing suitable products that contribute to enhancing treatment effectiveness and the quality of patient care.”

Mr. Thang also emphasized that as the healthcare sector increasingly focuses on standardization and technology application, medical device companies need to play a proactive role in supporting healthcare professionals. “BMD aims to develop products that not only meet quality standards but also optimally support operational efficiency in hospitals and laboratories.”

Participation in this scientific and technical conference once again reaffirmed Benovas’ commitment to accompanying the development of Vietnam’s healthcare sector, strengthening connections between businesses and the professional community, and contributing to the improvement of healthcare service quality.

In the coming time, Benovas will continue to promote research and product development activities while expanding cooperation with domestic and international partners, aiming to deliver effective, safe, and market-oriented medical device solutions that meet the growing demands of the healthcare industry.

During the meeting, shareholders reviewed and approved the 2025 operational reports of the Board of Directors, Board of Management, and Supervisory Board, while also discussing the Company’s operational plans for 2026. The AGM additionally approved proposals regarding the 2026 business plan, separate and consolidated audited financial statements for 2025, the selection of the auditing firm for 2026, and other matters under the authority of the General Meeting of Shareholders.

In 2025, Vietnam’s pharmaceutical industry continued to face increasingly intense competition from regional and international markets. In response to these challenges, Duoc Cuu Long Pharmaceutical Joint Stock Company (DCL) focused on evaluating and forecasting business conditions while implementing effective management strategies and solutions across all production and business activities. Supported by the strategic vision of F.I.T Group and DCL’s medium- and long-term development orientation, along with short-term initiatives such as digital transformation projects, investment in research and manufacturing upgrades, business cooperation, nationwide distribution network expansion, and export planning, DCL maintained stable operations and achieved 80% of the revenue target approved at the 2025 Annual General Meeting of Shareholders.

The 2026 AGM of DCL was conducted via an online meeting format.

In 2026, the Board of Directors will continue directing the Executive Board to implement key tasks and flexible business management solutions aligned with market conditions, with a focus on the Company’s core business segments.

In the pharmaceutical sector, DCL is concentrating resources on two major projects: the EU-GMP Pharmaceutical Manufacturing Plant Project in Tay Ninh – Phase 1, including the construction of an EU-GMP-standard oncology drug manufacturing facility and supporting infrastructure, as well as the upgrade project for the pharmaceutical manufacturing plant in Vinh Long to EU-GMP standards. In 2026, DCL also plans to cooperate with foreign partners on a “Functional Food Manufacturing and Trading” project. With 50 years of investment and development, pharmaceutical products manufactured by Duoc Cuu Long have earned the trust of customers and patients thanks to their quality and reasonable pricing. In addition to its existing manufacturing portfolio, DCL is diversifying its product range by expanding into pharmaceutical trading products, enabling the Company to better understand market demand, expand OTC and ETC distribution networks, and contribute significantly to overall business performance.

In the medical device sector, DCL completed Phase 1 of the Benovas Medical Device Manufacturing Plant, which officially commenced operations in March 2025. The plant’s key product lines include syringes, infusion sets, butterfly needles, and blood collection tubes. In 2026, with a strategy focused on both market expansion, including exports, and investment expansion for Phase 2, the medical device segment targets revenue of VND 188 billion, of which exports are expected to contribute VND 26 billion. At the same time, the factory will expand production and develop additional high-margin specialized products in areas such as emergency resuscitation and dialysis. Currently, DCL is investing heavily in the factory to improve quality standards and pursue FDA 510(k) and CE certifications.

In the empty capsule manufacturing segment, with stable production capacity and a tightly controlled quality management system, DCL currently supplies more than 80% of Vietnam’s empty capsule market, reaffirming its role as the leading supplier in this field. Through maintaining product quality, optimizing production processes, and improving operational efficiency, DCL continues to hold the number one market share position in Vietnam’s empty capsule industry. The empty capsule manufacturing plant is equipped with advanced technology imported from Canada, ensuring high technical standards, product consistency, and the ability to meet the stringent requirements of the pharmaceutical market. The modern production lines enable the factory to operate stably at high capacity, thereby meeting the rapidly increasing demand of customers as the empty capsule market continues to grow strongly.

With a spirit of consensus, responsibility, and innovation, DCL’s 2026 Annual General Meeting of Shareholders concluded successfully, reaffirming the strong connection between the Company’s leadership and shareholders on the journey toward sustainable development. The strategic orientations approved at the AGM not only serve as guiding principles for production and business activities in 2026 but also reflect Duoc Cuu Long’s strong aspiration to strengthen its position in Vietnam’s and the region’s pharmaceutical and healthcare industries. With a solid foundation, Duoc Cuu Long confidently enters a new phase of development—more efficient, more innovative, and more breakthrough-oriented.

The second 2026 Annual General Meeting of Shareholders of TSC was held in an online format.

Amid ongoing domestic and global economic fluctuations, TSC has proactively developed solutions to improve operational efficiency. In the production segment, the Company has focused on streamlining processes, prioritizing key products, and enhancing operational efficiency—particularly in inventory management.

In terms of business operations, TSC and its subsidiaries have reorganized the distribution system toward a more centralized model to improve efficiency across each region. At the same time, the Company has placed emphasis on developing a specialized sales force tailored to each product group and specific market characteristics. Sales policies have also been flexibly adjusted to better meet the needs of different customer segments.

The 2026 Annual General Meeting of Shareholders of TSC concluded successfully.

Regarding corporate governance, the Company has strengthened the application of technology in sales management and supply chain operations, contributing to improved efficiency. In addition, TSC has established a clearer performance evaluation system and enhanced supervisory roles between the parent company and its subsidiaries to ensure close coordination across the entire system.

With the synchronized implementation of these solutions, TSC expects its production and business activities in 2026 to achieve positive improvements, thereby gradually enhancing revenue performance in the coming period.

In 2025, despite ongoing economic fluctuations, WestFood maintained stable operations and achieved revenue of VND 500 billion, an increase of over 20% compared to the previous year. In September 2025, WestFood officially inaugurated the WestFood Hau Giang Food Processing Factory, with a capacity of 30,000 tons of finished products per year, a total investment of over VND 666 billion, and spanning nearly 7 hectares. The WestFood Hau Giang factory is one of the largest agricultural processing plants in the Mekong Delta, producing a wide range of new, high-quality products, thereby promoting the development of raw material areas—not only King MD2 pineapples but also various other agricultural products. At the same time, the project affirms the value of linkage between WestFood and local farmers, helping the company secure raw material supply, ensure product quality, provide stable output and pricing for farmers, and create jobs for thousands of local workers.

Entering 2026, WestFood continues to aim at strengthening its position in the agricultural export processing sector, while proactively securing raw material sources and enhancing competitiveness in the international market. The company will focus on developing key products such as mango, MD2 pineapple, canned lotus seeds, and processed product lines; expanding markets; strengthening cooperation with major customers; and improving production quality in line with increasingly stringent standards. In parallel, WestFood will continue investing in technology, improving processes, upgrading machinery systems, ensuring stable operation of the WestFood Hau Giang factory, and promoting the development of raw material areas (MD2 pineapple, lotus seeds, mango, papaya, and other tropical fruits), while enhancing cost management to improve production efficiency.

On that basis, WestFood sets a revenue target of approximately VND 684 billion for 2026, aiming for sustainable growth and improved business efficiency. With a strengthened foundation and clear strategy, WestFood expects to further expand its operations, enhance product quality, and affirm the position of Vietnamese agricultural products in the international market.

At CMEF 2026, BMD set out several strategic objectives, with a key focus on identifying opportunities to develop new products in the medical consumables segment—a high-potential field that also demands increasingly stringent technical and quality standards. By directly accessing global technology trends, advanced manufacturing models, and international market demands, BMD aims to quickly adapt and apply these insights to its operations in Vietnam.

At the same time, the company is actively seeking reputable OEM partners to expand its product portfolio. In the near term, BMD plans to import and distribute essential medical consumables such as dialysis filters, bloodlines, IV cannulas, and catheters. These products are in high demand within healthcare systems and play a critical role in supporting effective patient treatment and care.

A key activity during the exhibition was BMD’s direct visits to OEM manufacturing facilities. This allowed the company to assess production capacity, quality standards, and operational processes of potential partners—an essential step to ensure that future collaborations meet strict requirements for safety and performance.

Beyond that, participation in CMEF also provided BMD with opportunities to expand its supply network for raw materials and components. The company actively explored partnerships with suppliers of plastic resins such as PP, PVC, and PET, as well as providers of assembly components and packaging materials, including films, blister paper, and IV bag pouches. Securing a stable supply chain not only ensures production continuity but also enhances the quality of finished products.

Attending CMEF 2026 marks a concrete step in BMD’s strategy to broaden its product portfolio and strengthen global connections. Through direct engagement with partners, factory visits, and exposure to the manufacturing ecosystem, the company has identified new directions for the next phase—from product development to technology investment and supply chain optimization.

The outcomes of the event go beyond trade promotion, laying a solid foundation for BMD to accelerate the implementation of its strategic plans and gradually reinforce its position in the medical consumables industry.

After three days of exciting competition, the 67th National Marathon and Long Distance Championship – Tien Phong Marathon 2026 left a lasting impression on participants. More than just a national-scale sporting event, it was a journey of emotions, determination, and endurance, associated with the meaningful message: “Embrace the Dawn” – welcoming new, positive, and energetic beginnings.

Vikoda accompanied runners on their journey to “Embrace the Dawn” at the Tien Phong Marathon 2026.

As a Gold Sponsor and Exclusive Water Sponsor, Vikoda provided its original natural alkaline mineral water sourced from the Danh Thanh spring (Khanh Hoa), replenishing the “original rhythm of life” for thousands of athletes along every route. Vikoda’s presence went beyond simply supplying drinking water—it enhanced the overall race experience, helping each stride become steadier and more enduring.

On every racecourse, speed may create momentary advantages, but endurance ultimately determines the journey. Understanding this, Vikoda delivered its “mineral reserve” – a natural alkaline mineral source that helps runners maintain stamina and performance through to the finish line. With a natural alkalinity of pH 9.0, Vikoda mineral water not only supports hydration but also helps balance the body’s internal state, especially during high-intensity activities.

Vikoda supported participants in successfully reaching the finish line.

In addition, Vikoda stands out for its natural mineral content with an ideal TDS level ranging from 100–400 mg/l. Essential minerals such as H₂SiO₃, HCO₃⁻, Na⁺, K⁺, Ca²⁺ play an important role in maintaining electrolyte balance, supporting metabolism, and enhancing immunity. This balanced composition allows the body to absorb efficiently without overload, while still delivering optimal benefits—particularly important for those with active lifestyles.

Vikoda’s reputation is also built on its “5 Good” standards—a consistent commitment to quality. From its clean mineral source directly extracted from the natural alkaline Danh Thanh spring, located within a 35-hectare protected zone, to its closed production process, everything is designed to preserve the original value of the source from the very beginning. This foundation is what sets Vikoda apart and makes it a trusted choice for consumers.

Vikoda was honored to be the Gold Sponsor and Exclusive Water Sponsor of the 2026 Tien Phong Marathon – a major event in Vietnam’s running community.

For Vikoda, partnering with the Tien Phong Marathon goes beyond a sporting event; it is a journey to inspire a proactive healthy lifestyle and contribute to building a more active and sustainable community. This also reflects the brand’s long-term commitment to fostering a healthier, stronger, and more globally connected Vietnam. “Embrace the Dawn” is not only the start of a new day, but also a symbol of positive beginnings—and on that journey, Vikoda is proud to be a sustainable source of energy, accompanying the community in writing inspiring milestones with every step.

Notably, 2026 marks the 22nd time Vikoda has been voted for this prestigious title by consumers—a number that reflects not only consistent product quality but also the lasting trust the market has placed in the brand. In an increasingly competitive landscape, maintaining such trust for more than two decades is no easy feat; it requires persistence, transparency, and continuous innovation.

Vikoda proudly celebrates its 22nd recognition as a High-Quality Vietnamese Goods brand.

Alongside this 22-year milestone, Vikoda also proudly enters its 36th year of establishment and development. From its early days of tapping natural mineral sources in Khanh Hoa, the brand has consistently strived to preserve the pure, original values of nature in every product. This commitment has shaped a distinct identity, enabling Vikoda not only to endure but to thrive sustainably in a dynamic market.

At the core of Vikoda’s value lies a development philosophy closely tied to community health. With the mission of “Inspiring a better life through superior health care products and services,” Vikoda goes beyond simply providing drinking water—it offers balance for modern living. In today’s fast-paced world, where self-care is often overlooked, even small choices like daily drinking water have become more important than ever.

Vikoda’s CEO, Ms. Nguyen Thi Nga, had the honor of receiving the High-Quality Vietnamese Goods certification, as voted by consumers.

Understanding this, Vikoda remains committed to preserving its precious natural alkaline mineral source—the key element behind its product quality. The mineral water is extracted from a natural alkaline spring in Khanh Hoa, formed over millions of years underground and enriched with essential trace minerals beneficial to health. Protecting and sustainably utilizing this resource is how Vikoda preserves its “original essence from gems within stone”—a core value that defines the brand.

Beyond product quality, Vikoda continuously improves its production technology and enhances quality control standards to meet the ever-growing expectations of consumers. From extraction and processing to bottling, every stage is strictly monitored to ensure that each product delivered retains its natural integrity and safety.

At the award ceremony, Vikoda also showcased a product experience booth, attracting significant interest from attendees.

The High-Quality Vietnamese Goods title is not only a recognition but also a “measure of trust” from consumers—the very people who directly experience and evaluate the products. For Vikoda, being honored 22 times is not a destination, but a motivation to keep improving, innovating, and spreading the values of healthy living to the community.

Vikoda’s 36-year journey is one of perseverance—steadfast in maintaining quality, sustaining trust, and pursuing its mission for the health of Vietnamese people. This is why the brand continues to receive long-term support from consumers nationwide.

Looking ahead, Vikoda will continue to uphold its core values while expanding its vision to bring Vietnamese products further onto the global stage. Yet wherever it goes, the brand remains committed to its original spirit—starting from nature’s purest elements to create the most sustainable values.

Vikoda is committed to preserving the original natural values in every product, serving community health and sustainable development.

“Original essence from gems within stone, enduring with Vietnamese trust” is not just a message—it is Vikoda’s enduring commitment throughout its development journey. With a strong foundation built over 36 years, Vikoda is well-positioned to conquer new milestones and continue accompanying Vietnamese consumers on their journey toward healthier living every day.